Plasma Vitronectin Predicts Response to Fluoropyrimidine-oxaliplatin (FOLFOX) Chemotherapy in Metastatic Colorectal Cancer

Video   Jul 21, 2015

 

Current assessment is based on computed tomography scans, approximately 6-8 weeks after treatment. Earlier molecular predictors of response would be highly beneficial for both patients and clinicians. We have investigated whether useful protein biomarkers could be found in patient plasma, through the use of an advanced MS technique known as SRM-MS. Here, we will discuss the discovery-through-validation pipeline of identifying and validating clinically-relevant biomarkers that can be rapidly translated into the clinic. Briefly, we examined whether the type of blood collection tube would impact on SRM measurement of plasma proteins, in addition to examining the stability of the selected plasma proteome over a 19 week time-course. We then applied SRM to monitor 31 plasma proteins in a trial cohort of advanced CRC patients receiving FOLFOX chemotherapy. Our results indicated that the baseline levels of plasma vitronectin were associated with chemotherapy response, which was successfully validated in a larger patient cohort using SRM and ELISA (n=29 patients). These findings pave the way for further testing in larger cohorts and could lead to more cost-effective and rational uses of systemic chemotherapy.

 
 
 
 

Recommended Videos

Pill for Better Diagnosis of Breast Cancer

Video

Researchers from the University of Michigan have developed a diagnostic imaging pill enabling the early and more accurate diagnosis of cancerous tumors in breast tissue.

WATCH NOW

CellStreamâ„¢ Benchtop Flow Cytometer for Sensitive Cell Analysis

Video

The new CellStreamâ„¢ benchtop flow cytometer delivers unparalleled sensitivity and flexibility for cell and particle analysis.

WATCH NOW

How 2D-LC is Used in Forensic Science at Boston University Medical School - Behind the Science

Video

The focus of a forensic toxicology laboratory is to determine the presence or absence of drugs in biological samples. Often times when it comes to drug testing, the sensitivity of the analytical method is critical because scientists need to detect chemical compounds in very small amounts. Multidimensional liquid chromatography (2DLC) is one option forensics labs can use to test biological samples, such as urine, blood, oral fluid, hair, to determine if an illicit drug or toxin played a role in a person's death.

WATCH NOW

 

Like what you just watched? You can find similar content on the communities below.

Analysis & Separations Cancer Research Diagnostics Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy